APLS · Apellis Pharmaceuticals, Inc.
Market Cap
$5.25B
Shares
128.02M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $10,957,451 |
| Caroline Baumal | Chief Medical Officer | $4,407,128 |
| Adam Townsend | Chief Commercial Officer | $3,956,053 |
| Timothy Sullivan | Chief Financial Officer | $3,949,075 |
| David Watson | General Counsel | $3,891,721 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $10,373,049 |
| David Watson | General Counsel | $4,885,889 |
| Caroline Baumal | Chief Medical Officer | $4,430,459 |
| Timothy Sullivan | Chief Financial Officer | $3,737,235 |
| Adam Townsend | Chief Commercial Officer | $3,714,246 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $9,203,556 |
| Timothy Sullivan | Chief Financial Officer | $3,546,148 |
| Adam Townsend | Chief Commercial Officer | $3,096,029 |
| Pascal Deschatelets | Chief Scientific Officer | $3,082,479 |
| David Watson | General Counsel | $3,069,773 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $9,122,039 |
| Timothy Sullivan | Chief Financial Officer | $3,075,916 |
| Pascal Deschatelets | Chief Scientific Officer | $2,647,975 |
| Adam Townsend | Chief Commercial Officer | $2,640,819 |
| Federico Grossi | M.D., Ph.D. Chief Medical Officer | $2,616,139 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $9,275,425 |
| Timothy Sullivan | Chief Financial Officer | $3,485,149 |
| Nur Nicholson | Chief Technical Operations Officer | $3,022,154 |
| Pascal Deschatelets | Chief Scientific Officer | $2,918,082 |
| Adam Townsend | Chief Commercial Officer | $2,901,007 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $4,267,182 |
| Lucia Celona | Former Chief People Officer | $3,763,062 |
| Thomas Lackner | Senior Vice President, Head of Europe | $2,108,720 |
| Pascal Deschatelets | Chief Scientific Officer | $1,821,228 |
| Timothy Sullivan | Chief Financial Officer | $1,719,303 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $4,074,540 |
| Pascal Deschatelets | Chief Scientific Officer | $1,862,357 |
| Timothy Sullivan | Chief Financial Officer | $859,752 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Timothy Sullivan | Chief Financial Officer | $2,296,699 |
| Cedric Francois | M.D., Ph.D. President & Chief Executive Officer | $1,662,972 |
| Pascal Deschatelets | Chief Operating Officer | $869,548 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mikael Dolsten, M.D., Ph.D. | Class I director | Appointed | 2026-03-02 |
| Craig A. Wheeler | Class III director | Appointed | 2025-04-21 |
| Adam Townsend | Chief Operating Officer | Resigned | 2025-01-13 |
| Keli Walbert | Class II director | Appointed | 2025-01-13 |
| Adam Townsend | Chief Operating Officer | Appointed | 2024-01-22 |
| Dr. Caroline Baumal | Chief Medical Officer | Appointed | 2023-01-09 |
| Caroline Baumal, M.D. | Chief Medical Officer | Appointed | 2023-01-05 |